PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
29956027-0	2018	Prospective study of relevance of 123I-MIBG myocardial scintigraphy and clonidine GH test to distinguish Parkinson"s disease and multiple system atrophy.	Clonidine	72-81	gamma-glutamyl hydrolase	Homo sapiens	82-84	
12242540-6	2002	However, taking the difference in prevalence of PD and SND into account, and because of the low likelihood ratios of the test, an increase of GH after clonidine increases the pre-test probability for PD by about only 5 %, while an absent response of GH also increases the pre-test probability for SND by about 5 %.	Clonidine	151-160	gamma-glutamyl hydrolase	Homo sapiens	142-144	
1522942-8	1992	GH levels after clonidine were blunted in all subjects but one AD patient, probably due to an age-dependent attenuation frequently observed in subjects over 45 years of age.	Clonidine	16-25	gamma-glutamyl hydrolase	Homo sapiens	0-2	
9217760-5	1997	METHODS: Clonidine is a centrally active alpha 2-adrenoceptor agonist that raises concentrations of GH in serum in healthy people and those with pure autonomic failure (with peripheral lesions), but not in those with MSA (with a central autonomic deficit).	Clonidine	9-18	gamma-glutamyl hydrolase	Homo sapiens	100-102	
9217760-9	1997	FINDINGS: Clonidine raised serum GH concentrations in patients with idiopathic Parkinson"s disease (median increase 8.98 [IQR 6.6-16.6] mU/L), normal participants (13.2 [7.0-18.6] mU/L), and patients with pure autonomic failure (12.5 [5.6-18.2] mU/L).	Clonidine	10-19	gamma-glutamyl hydrolase	Homo sapiens	33-35	
9217760-11	1997	The GH response to clonidine in idiopathic Parkinson"s disease was significantly different from that in MSA-P (p < 0.0002).	Clonidine	19-28	gamma-glutamyl hydrolase	Homo sapiens	4-6	
9217760-13	1997	INTERPRETATION: The GH responses to clonidine clearly differentiated idiopathic Parkinson"s disease from MSA-C and MSA-P.	Clonidine	36-45	gamma-glutamyl hydrolase	Homo sapiens	20-22	
9217760-15	1997	The clonidine-GH test may provide further insight into central neurotransmitter and alpha 2-adrenoceptor-hypothalamic abnormalities in MSA.	Clonidine	4-13	gamma-glutamyl hydrolase	Homo sapiens	14-16	
8047638-2	1994	Since the central alpha 2 adrenergic agonist clonidine is widely used as a therapeutic agent in GTS, the present study aimed at assessing whether GH release after clonidine, representing central alpha 2-adrenergic receptor sensitivity, was altered in GTS.	Clonidine	163-172	gamma-glutamyl hydrolase	Homo sapiens	146-148	
32034477-0	2020	Clonidine GH stimulation test to differentiate MSA from idiopathic late onset cerebellar ataxia: a prospective, controlled study.	Clonidine	0-9	gamma-glutamyl hydrolase	Homo sapiens	10-12